How Can We Help?

< All Topics
You are here:
Print

CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

CCCDTD5- Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

Previous Canadian Study of Health and Aging: study methods and prevalence of dementia
Next CCCDTD5: Individual and community-based psychosocial and other non-pharmacological interventions to support persons living with dementia and their caregivers
Table of Contents